Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Clin Exp Obstet Gynecol ; 43(4): 619-620, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-29734564

RESUMO

The authors present the case of a postpartum splenic rupture induced probably by iatrogenic injury (recent vaginal delivery with a prolonged expulsion with uterine fundus compression) including the left hypochondria region costal grid. The case was solved with splenic preservation and achieving hemostasis only by local plugging and Gelaspon. The case raised also other problems regarding the etiology of splenic rupture, in establishing a causal relationship between a intrapartum splenic injury, and the three episodes of inferior genital tract hemorrhaging, in establishing the cause of the infectious syndrome from the 24h postpartum day, (parietal infection or splenic abscess requiring splenectomy).


Assuntos
Complicações do Trabalho de Parto/terapia , Transtornos Puerperais/etiologia , Transtornos Puerperais/terapia , Ruptura Esplênica/etiologia , Ruptura Esplênica/terapia , Adulto , Feminino , Humanos , Doença Iatrogênica , Complicações do Trabalho de Parto/diagnóstico , Complicações do Trabalho de Parto/etiologia , Gravidez , Transtornos Puerperais/diagnóstico , Esplenectomia , Ruptura Esplênica/diagnóstico
2.
Curr Health Sci J ; 41(3): 197-203, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-30534422

RESUMO

IBD (inflammatory bowel diseases) represent chronic idiopathic inflammatory diseases, prone to relapse in the digestive tract; it is estimated that they result from the interaction of the intestinal microbiome with the intestinal immune system. The inflammatory microbiome exerts multiple beneficial roles. Perhaps the central element to developing IBD is dysbiosis; there is still an incompletely established association between intestinal microbiome changes in patients with IBD and SIBO (small intestinal bacterial overgrowth). Influencing the intestinal microbiome may play an adjuvant therapeutic role in the treatment of IBD. We present a synthesis of the connections between the entities mentioned above.

3.
Dig Dis Sci ; 58(5): 1244-9, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23306840

RESUMO

BACKGROUND: The role of oxidative stress in inflammatory bowel diseases (IBD) has been extended lately from a simple consequence of inflammation to a potential etiological factor, but the data are still controversial. Active disease has been characterized before by an enhanced production of reactive oxygen species and the increased peroxidation of lipids, but patients in remission were generally not considered different from healthy people in terms of oxidative stress. AIMS: We evaluated the antioxidant defense capacity and lipid peroxidation status in the serum of patients with active and non-active disease compared with healthy matched control subjects. METHODS: The study included 20 patients with confirmed IBD in clinical and biological remission, 21 patients with active disease, and 18 controls. We determined the serum levels of two antioxidant enzymes, superoxide dismutase (SOD) and glutathione peroxidase (GPX), and a lipid peroxidation marker, malondialdehyde (MDA). RESULTS: Active disease patients had an increased activity of both SOD and GPX, as well as significant high values of MDA versus controls. Furthermore, patients being in remission had significantly lower values of antioxidant enzymes (SOD and GPX) and increased lipid peroxidation measured by MDA serum levels, as compared with healthy control subjects. CONCLUSIONS: Our study confirmed the presence of high oxidative stress in active IBD. More importantly, we have demonstrated a lower antioxidant capacity of patients in remission versus control group. This may represent a risk factor for the disease and can be an additional argument for the direct implication of oxidative stress in the pathogenesis of IBD.


Assuntos
Glutationa Peroxidase/metabolismo , Doenças Inflamatórias Intestinais/enzimologia , Peroxidação de Lipídeos , Estresse Oxidativo , Superóxido Dismutase/metabolismo , Adulto , Proteína C-Reativa/metabolismo , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Malondialdeído/sangue , Pessoa de Meia-Idade , Estudos Prospectivos , Adulto Jovem
4.
Chirurgia (Bucur) ; 106(3): 395-400, 2011.
Artigo em Romano | MEDLINE | ID: mdl-21853752

RESUMO

The Budd-Chiari syndrome represents the obstruction of hepatic veins usually due to a hepatocarcinoma. We present the case of a 68 year old patient, in medical evidence for ten years with a Child A ethanolic liver cirrhosis, who was admitted in emergency for hematemesis and melena. Clinical examination and the laboratory findings at the admittance revealed signs of decompensated cirrhosis and severe anemia. Ultrasound examination showed a cirrhotic liver with portal hypertension signs and a multinodular mass in the right lobe of the liver with portal, biliary and right hepatic vein invasions extended to inferior caval vein. In upper digestive endoscopy stage IV esophageal varices were evidenced with signs of recent bleeding (sclerotherapy was performed) along with gastric varices and portal gastropathy. The particularity of the case consists in the invasive complications of the hepatocarcinoma regarding hepatic and inferior caval veins wich defines the Budd-Chiari syndrome (posthepatic portal hypertension added to the intrahepatic and prehepatic ones), the invasions of the biliary tract and portal vein being more frequent.


Assuntos
Síndrome de Budd-Chiari/diagnóstico , Carcinoma Hepatocelular/diagnóstico , Neoplasias Hepáticas/diagnóstico , Idoso , Anemia Ferropriva/etiologia , Biomarcadores/sangue , Síndrome de Budd-Chiari/sangue , Síndrome de Budd-Chiari/complicações , Síndrome de Budd-Chiari/diagnóstico por imagem , Carcinoma Hepatocelular/sangue , Carcinoma Hepatocelular/complicações , Carcinoma Hepatocelular/diagnóstico por imagem , Diabetes Mellitus Tipo 2/complicações , Varizes Esofágicas e Gástricas/diagnóstico por imagem , Varizes Esofágicas e Gástricas/terapia , Seguimentos , Hematemese/etiologia , Humanos , Cirrose Hepática Alcoólica/diagnóstico , Neoplasias Hepáticas/sangue , Neoplasias Hepáticas/complicações , Neoplasias Hepáticas/diagnóstico por imagem , Masculino , Melena/etiologia , Escleroterapia , Tomografia Computadorizada por Raios X , Resultado do Tratamento , Ultrassonografia , Veia Cava Inferior/diagnóstico por imagem , alfa-Fetoproteínas/metabolismo
5.
Rev Med Chir Soc Med Nat Iasi ; 99(1-2): 56-62, 1995.
Artigo em Romano | MEDLINE | ID: mdl-9524657

RESUMO

The common bile duct (CBD) stones often gives real difficulties of diagnosis and treatment. The ultrasound (US) does not offer in a significant percentage of cases certain diagnostic data, and the unconventional imaging techniques such as computer tomography (CT) are yet less accessible. ERCP appeared in the last period as an optional method for the diagnosis of common bile duct stones, and, moreover, permitted the development of the nonsurgical treatment possibilities. ES and the extraction of stones revealed in this frame as preferable, especially in the high surgical risk cases. This study presents the results of ERCP performed in 547 and the therapeutic value of ES in 284 cases with CBD stones (conclusions of the ERCP and ES used in the clinical practice, in our clinic, in the last three years). In 81.69% cases ES managed the dezobstruction of the CBD, with a frequency of complications of 4.33% and a related mortality rate of 0.78%.


Assuntos
Colangiopancreatografia Retrógrada Endoscópica , Cálculos Biliares/diagnóstico por imagem , Cálculos Biliares/cirurgia , Esfinterotomia Endoscópica , Adulto , Idoso , Idoso de 80 Anos ou mais , Colangiopancreatografia Retrógrada Endoscópica/efeitos adversos , Ducto Colédoco/diagnóstico por imagem , Ducto Colédoco/cirurgia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Esfinterotomia Endoscópica/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...